Diurnal cortisol and decision making under risk in problem gambling.

The aim of this study was to assess the influence of diurnal cortisol profile on decision making under risk in individuals with problem gambling and a healthy control group. We examined the relationship between diurnal cortisol, assessed over the course of 2 days, and a battery of tasks that assessed decision making under risk, including the Columbia Card Task and the Cups Task. Thirty individuals with problem gambling and 29 healthy individuals took part in the study. Those with problem gambling showed blunted diurnal cortisol and more risk taking behavior compared with those in the healthy control group. Blunted cortisol profile was associated with more risky behavior and less sensitivity to losing money in problem gambling. These findings suggest that blunted stress physiology plays a role in specific parameters of risky decision making in problem gambling

Bayes Factors for Mixed Models: a Discussion

van Doorn et al. (2021) outlined various questions that arise when conducting Bayesian model comparison for mixed effects models. Seven response articles offered their own perspective on the preferred setup for mixed model comparison, on the most appropriate specification of prior distributions, and on the desirability of default recommendations. This article presents a round-table discussion that aims to clarify outstanding issues, explore common ground, and outline practical considerations for any researcher wishing to conduct a Bayesian mixed effects model comparison

Dehydrogenative boron homocoupling of an amine-borane.

A meeting of borons: The homocoupling of a B-B bond in an amine-borane is reported to give a diborane coordinated to a RhI metal center (see picture; C gray/black, O red, P blue, B green, N orange). The pathway for the occurrence of this reaction was also studied using density functional theory to calculate the free energies of each intermediate. Copyright © 2013 WILEY-VCH Verlag GmbH and Co. KGaA, Weinheim

Systemic thrombolysis for acute, severe Budd-Chiari syndrome

Budd-Chiari syndrome (BCS) or hepatic venous outflow obstruction, is a rare and complex clinical entity, with diverse aetiology and a wide range of presentations. Its rarity and heterogeneity create significant challenges for evidence-based clinical decision-making, particularly in the even more infrequent setting of acute BCS presentation. Here we present the case of a young woman with acute, severe BCS, where treatment alternatives were limited due to a significant IVC thrombus burden. A clearly defined acute onset allowed the prompt use of systemic thrombolysis, conducted in consultation with a multi-disciplinary team of clinicians, with close monitoring for both treatment response and complications. Her treatment resulted in resolution of hepatic vein occlusion and prevention of the potentially significant clinical sequelae. We review the literature and discuss current opinion in the management of BCS